Product
PTC857
1 clinical trial
1 indication
Indication
Amyotrophic lateral sclerosisClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effects of PTC857 in Adult Subjects With Amyotrophic Lateral Sclerosis (CARDINALS)Status: Active (not recruiting), Estimated PCD: 2024-07-31